07 August 2024

The Pfizer Foundation* contributes to antibiotic resistance innovation prize

The prize fund for the Trinity Challenge on Antimicrobial Resistance was supported by the Pfizer Foundation. The ability of the Trinity Challenge to identify and support innovative solutions to global health threats depends on donations such as this one.

Given most of the current data available on antibiotic resistance is from high-income countries, funding needs to be secured to power potential solutions that could both tackle antibiotic resistance and help fill this data gap. For example, the Challenge has encouraged solutions that might develop new tools to capture community data; combine data sets in novel ways to increase understanding, or provide new ways to harness data to implement action and policy change.

The donation made by The Pfizer Foundation to the prize fund has increased the potential impact of the solutions teams that were awarded funding.

You can read more about the winners of the Trinity Challenge on Antimicrobial Resistance here.

Professor Marc Mendelson, Director, the Trinity Challenge, said: “Through this Challenge, we wanted to attract and support the best and brightest minds across sectors to share ideas on how to protect the power of antibiotics, particularly in lower- and middle-income countries who suffer the greatest impact from this growing threat. I am extremely pleased to have been able to work with The Pfizer Foundation on this Challenge, and that they have contributed to the prize funding that is now going to the most promising solutions for antibiotic resistance.”

Jenny Sia, The Pfizer Foundation, said: “AMR is a global public health issue that threatens to eliminate some our most powerful tools to combat disease. We, at The Pfizer Foundation, recognize the importance and urgency of finding and executing solutions to combat AMR and are proud to partner with this Challenge to support the teams seeking innovative ways to address AMR.”

*The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions

 

Latest News

Preserve to Protect – a new awareness drive on antimicrobial resistance from the Union for International Cancer Control (UICC)

The Trinity Challenge has partnered with the Union for International Cancer Control (UICC) to raise awareness about antimicrobial resistance and particularly the serious threat it poses to people living with cancer.

There has been substantial progress in cancer care in the past decades, with key advances in surgery, radiotherapy, and medicines including immunotherapies. But the increasing inability of medicines to address certain infections can undermine efforts to treat cancer patients.

Read more

Dame Sally Davies: The world is facing an antibiotic emergency – a data-led plan of action is needed now

[Originally published in The Guardian] Global leaders are meeting to address the threat posed by antimicrobial resistance – millions will die unless solutions are found. Over the next 25 years, someone will die every three minutes from common, preventable and formerly treatable health conditions, simply because the antibiotics we use to treat them will have […]

Read more

BBC News: When vets are scarce what can farmers do?

[Originally published on BBC News online]

Quang Doan Hong is a busy person. The accountant, who lives with his family in Hưng Yên, Vietnam, also owns a farm with about 600 pigs.

He’s had to learn quickly about pig health, from which vaccines are effective to when to use antibiotics.

“When the weather changes, I give the pigs antibiotics,” Mr Hong says. In his experience, rapid changes between sunny and rainy weather make it necessary to administer antibiotics for respiratory and diarrhoeal diseases.

Read more